Work

Subscription-Based Pricing for Lenacapavir—Learning From Hepatitis C and Cabotegravir

Year: 2026

Type: article

Source: JAMA

DOI: 10.1001/jama.2025.24404

Authors: Michael R. Rose, Charles Flexner, Victor Roy

Institutions: Johns Hopkins University, Johns Hopkins Medicine, Leonard Davis Institute of Health Economics, University of Pennsylvania

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7119034851

FWCI: 7.377

Cites: 6

Cited by: 1

Related to: